Ascites affects the benefit of carvedilol on patients with liver cirrhosis and esophageal and gastric varices

Documenti analoghi

• Long‐term benefit of SGLT2 inhibitors to prevent heart failure hospitalization in patients with diabetes, with potential time‐varying benefit
  di: Yasuo Takahashi, et al.
  Pubblicazione: (2024)
• Association of liver fibrosis scores with all‐cause and cardiovascular mortality in patients with heart failure
  di: Ziyu Guo, et al.
  Pubblicazione: (2024)
• Efficacy and safety of adamgammadex for reversing rocuronium‐induced deep neuromuscular blockade: A multicenter, randomized, phase IIb study
  di: Yanhua Zhao, et al.
  Pubblicazione: (2024)
• Efficacy, safety, and pharmacokinetics of isoniazid affected by NAT2 polymorphisms in patients with tuberculosis: A systematic review
  di: Thanakorn Surarak, et al.
  Pubblicazione: (2024)
• Rapid identification and phenotyping of nonalcoholic fatty liver disease patients using a machine‐based approach in diverse healthcare systems
  di: Anna O. Basile, et al.
  Pubblicazione: (2024)